Published in Mol Biochem Parasitol on June 25, 1999
Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob Agents Chemother (2003) 1.14
Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparum. Antimicrob Agents Chemother (2000) 1.04
Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa. Malar J (2006) 0.86
Genetics of chloroquine-resistant malaria: a haplotypic view. Mem Inst Oswaldo Cruz (2013) 0.78
Malaria parasite genome scan: insights into antimalarial resistance. Parasitol Res (2010) 0.76
Performance of the OptiMAL malaria antigen capture dipstick for malaria diagnosis and treatment monitoring at the Hospital for Tropical Diseases, London. Br J Haematol (2000) 3.61
Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Mol Biochem Parasitol (1995) 2.29
Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol (1995) 1.71
In vitro study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-micro test. Am J Trop Med Hyg (1983) 1.69
In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1993) 1.57
In vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparum. Antimicrob Agents Chemother (1994) 1.55
Desipramine or cyproheptadine for reversing chloroquine resistance? Lancet (1990) 1.52
Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay. Exp Parasitol (1995) 1.51
Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infect Immun (1993) 1.48
Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Exp Parasitol (1996) 1.48
Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon. Lancet (1991) 1.41
[Plasmodium falciparum malaria: type R1 resistance to quinine in west Africa]. Presse Med (1998) 1.38
Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Mol Biochem Parasitol (2001) 1.36
In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. Antimicrob Agents Chemother (1999) 1.35
In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1994) 1.28
In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Ann Trop Med Parasitol (1994) 1.21
[Plasmodium falciparum: interpretation of the semi-microtest of in vitro chemosensitivity by H3-hypoxanthine incorporation]. Pathol Biol (Paris) (1984) 1.20
In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. Br J Clin Pharmacol (1992) 1.19
Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum. Lancet (1984) 1.16
Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. Eur J Clin Pharmacol (1987) 1.15
In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1992) 1.13
Reversal of chloroquine resistance with desipramine in isolates of Plasmodium falciparum from Central and West Africa. Trans R Soc Trop Med Hyg (1991) 1.12
Severe chloroquine-resistant falciparum malaria in Gabon with decreased sensitivity to quinine. Trans R Soc Trop Med Hyg (1986) 1.07
Unreliability of Dill Glazko test in detecting chloroquine in urine. Lancet (1985) 1.06
Chloroquine-resistant falciparum malaria in Benin. Lancet (1986) 1.06
Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparum. Antimicrob Agents Chemother (2000) 1.04
In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1993) 1.02
Plasmodium falciparum: detection of P-glycoprotein in chloroquine-susceptible and chloroquine-resistant clones and isolates. Exp Parasitol (1995) 1.02
High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations. Trans R Soc Trop Med Hyg (2003) 1.01
Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance. Antimicrob Agents Chemother (1985) 1.01
Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Exp Parasitol (1995) 1.00
Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro. Ann Trop Med Parasitol (1991) 1.00
Chloroquine-resistant falciparum malaria in Mauritania. Lancet (1995) 0.97
Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Ann Trop Med Parasitol (1985) 0.97
Levels of cytokines in plasma during Plasmodium falciparum malaria attacks. J Clin Microbiol (1991) 0.97
Treatment of imported cases of falciparum malaria in France with halofantrine. Trans R Soc Trop Med Hyg (1986) 0.97
Failure of anti-malarial prophylaxis with mefloquine in Africa. Trans R Soc Trop Med Hyg (1991) 0.96
Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Exp Parasitol (1983) 0.95
[In vitro activity of various antimalarials (chloroquine, amodiaquine, quinine and mefloquine) against 32 isolates of Plasmodium falciparum in French Guiana]. Bull Soc Pathol Exot Filiales (1988) 0.94
In vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum. Antimicrob Agents Chemother (1992) 0.93
In vitro activity of pyronaridine against African strains of Plasmodium falciparum. Ann Trop Med Parasitol (1992) 0.93
Short-term in vitro culture of Plasmodium vivax and P. ovale for drug-susceptibility testing. Parasitol Res (1994) 0.92
Molecular survey of Plasmodium falciparum resistance in south-eastern Iran. Ann Trop Med Parasitol (2003) 0.92
Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. Am J Trop Med Hyg (1994) 0.91
Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum. J Antimicrob Chemother (2002) 0.91
Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial. Am J Trop Med Hyg (2001) 0.91
Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal. Bull World Health Organ (1992) 0.90
Association between antifol resistance in vitro and DHFR gene point mutation in Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg (1996) 0.90
Dichlorquinazine (alpha 4-aminoquinoline) effective in vitro against chloroquine-resistant Plasmodium falciparum. Lancet (1983) 0.89
Cytoadherence characteristics to endothelial receptors ICAM-1 and CD36 of Plasmodium falciparum populations from severe and uncomplicated malaria cases. Parasite (2008) 0.89
Sudden increase in number of isolates of Plasmodium falciparum resistant to chloroquine in Madagascar. Trans R Soc Trop Med Hyg (1990) 0.89
Reversal of chloroquine resistance with cyproheptadine in 'wild' strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1991) 0.89
Chloroquine-resistant Plasmodium falciparum malaria in Senegal. Trans R Soc Trop Med Hyg (1990) 0.89
[A fatal case of chloroquine-resistant neuromalaria in a traveller to Cameroon]. Bull Soc Pathol Exot Filiales (1986) 0.88
Evaluating the efficacy of chloroquine in febrile Guinean children infected with Plasmodium falciparum by a simplified in vivo test. Bull World Health Organ (1992) 0.87
Reduction of coma by quinine loading dose in falciparum cerebral malaria. Lancet (1991) 0.87
Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria. Antimicrob Agents Chemother (1991) 0.87
Reduced sensitivity of Plasmodium falciparum to mefloquine in West Africa. Lancet (1988) 0.87
Cloning and sequencing of Plasmodium falciparum DNA fragments containing repetitive regions potentially coding for histidine-rich proteins: identification of two overlapping reading frames. Biochem Biophys Res Commun (1987) 0.87
In vitro activities of novel catecholate siderophores against Plasmodium falciparum. Antimicrob Agents Chemother (1996) 0.87
In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine. Antimicrob Agents Chemother (1991) 0.87
In vitro activity of bisquinoline WR268,668 against African clones and isolates of Plasmodium falciparum. Am J Trop Med Hyg (1994) 0.87
Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000. Euro Surveill (2002) 0.87
Type RI resistance to halofantrine in West Africa. Trop Med Parasitol (1991) 0.87
Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients. Eur J Clin Pharmacol (1994) 0.86
Predictive factors of severe disease secondary to falciparum malaria among travelers. Pathol Biol (Paris) (2010) 0.86
Antimalarial activity in vitro of the N-desbutyl derivative of halofantrine. Trans R Soc Trop Med Hyg (1992) 0.85
In vitro reversal of chloroquine resistance with chlorpheniramine against African isolates of Plasmodium falciparum. Jpn J Med Sci Biol (1994) 0.85
[Geographic approach to the epidemiology of chloroquine-resistance of Plasmodium falciparum in tropical Africa]. Ann Soc Belg Med Trop (1991) 0.85
Evolution of chloroquine resistance in central and west Africa. Trop Med Parasitol (1993) 0.84
Activity in vitro of doxycycline against multidrug-resistant Plasmodium falciparum. Trans R Soc Trop Med Hyg (1993) 0.84
Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria. Antimicrob Agents Chemother (1989) 0.83
[Surveillance of Plasmodium falciparum drug sensitivity in Yaounde and its surroundings (Cameroon). In vivo and in vitro study]. Bull Soc Pathol Exot Filiales (1989) 0.83
Susceptibility of Plasmodium falciparum to a peroxidase-mediated oxygen-dependent microbicidal system. Infect Immun (1988) 0.83
In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1995) 0.83
In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains. Bull Soc Pathol Exot (1997) 0.82
Antibodies to the PF155 antigen of Plasmodium falciparum: measurement by cell-ELISA and correlation with expected immune protection. Am J Trop Med Hyg (1987) 0.82
[Stability of P. Falciparum resistance to chloroquine between 1987 and 1989 in Mounana, Gabon]. Bull World Health Organ (1992) 0.82
DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France. Trans R Soc Trop Med Hyg (1997) 0.82
Potentiation of chloroquine activity against Plasmodium falciparum by the peroxidase-hydrogen peroxide system. Antimicrob Agents Chemother (1990) 0.82
Absence of antimalarial activity or interaction with mefloquine enantiomers in vitro of the main human metabolite of mefloquine. Trans R Soc Trop Med Hyg (1991) 0.82
Plasmodium falciparum: in vitro drug interaction between chloroquine and enantiomers of amlodipine. Exp Parasitol (1991) 0.81
Blood samples and chloroquine assay. Lancet (1983) 0.81
In vitro antimalarial activity and chloroquine potentiating action of two bisbenzylisoquinoline enantiomer alkaloids isolated from Strychnopsis thouarsii and Spirospermum penduliflorum. Planta Med (1992) 0.81
Molecular characterisation of airport malaria: four cases in France during summer 1999. Parasite (2002) 0.81
[Stimulation of the chemiluminescence of human polymorphonuclear leukocytes in various stages of the intraerythrocyte development of Plasmodium falciparum]. C R Seances Soc Biol Fil (1988) 0.80
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. III. Studies in three regions of the interior]. Arch Inst Pasteur Madagascar (1984) 0.80
Susceptibility of African isolates of Plasmodium falciparum to artemisinin (qinghaosu). Trop Med Parasitol (1992) 0.80
Application of an in vitro semi-microtest to the study of drug sensitivity of 66 Plasmodium falciparum isolates from 15 countries. Trans R Soc Trop Med Hyg (1984) 0.80
Chloroquine-resistant falciparum malaria in the Congo. Lancet (1985) 0.80
The interferon compartment of the immune response in human malaria: I. Interferon inducers in Plasmodium falciparum cultures. J Interferon Res (1985) 0.80
[The OCCGE (Organisation de Coordination et de Coopération pour la Lutte contre les Grandes Endémies) and the surveillance of the drug sensitivity of Plasmodium falciparum to antimalarials]. Bull Soc Pathol Exot Filiales (1987) 0.79
[Drug sensitivity of malaria in a population of children in Pointe-Noire, Congo, in the first half of 1986]. Bull Soc Pathol Exot Filiales (1987) 0.79
Anti-erythrocyte autoimmunisation during chronic falciparum malaria. Lancet (1981) 0.79
Geographic diversity of Plasmodium falciparum antibodies in Madagascar. Lancet (1985) 0.79
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. I. Study in two regions of the west coast]. Arch Inst Pasteur Madagascar (1984) 0.79
Plasmodium falciparum: pfcrt and DHFR mutations are associated with failure of chloroquine plus proguanil prophylaxis in travelers. J Infect Dis (2001) 0.79
[Anademic focus of leptospirosis at Fondem (U.R. of Cameroon)]. Bull Soc Pathol Exot Filiales (1978) 0.79